Ligand validation:6KVY

AVJ: N,N,N-trimethyl-histidine

AVJ is a Ligand Of Interest in 6KVY designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6KVY_AVJ_A_501	82%	58%	0.114	0.97	0.92	0.66	-	-	1	0	100%	1
6KTW_AVJ_A_503	90%	24%	0.086	0.969	2.06	1.25	2	1	2	0	100%	1
6KTV_AVJ_A_501	74%	9%	0.125	0.956	2.86	1.74	2	3	1	0	100%	1
6KTZ_AVJ_A_504	72%	46%	0.136	0.961	1.38	0.74	1	-	1	0	100%	1
8K5J_AVJ_A_502	92%	43%	0.062	0.953	1.14	1.12	1	1	0	0	100%	1
4X8E_AVJ_A_501	92%	27%	0.076	0.965	1.34	1.76	1	2	0	0	100%	1
6O6L_AVJ_B_501	90%	41%	0.094	0.978	1	1.33	-	1	0	0	100%	1
6FNQ_AVJ_B_401	88%	36%	0.089	0.963	1.58	1.03	2	1	0	0	100%	1
6QKJ_AVJ_B_502	84%	64%	0.102	0.963	0.8	0.55	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.